Brain network alterations in Alzheimer's disease measured by Eigenvector centrality in fMRI are related to cognition and CSF biomarkers
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Recent imaging studies have demonstrated functional brain network changes in patients with Alzheimer's disease (AD). Eigenvector centrality (EC) is a graph analytical measure that identifies prominent regions in the brain network hierarchy and detects localized differences between patient populations. This study used voxel‐wise EC mapping (ECM) to analyze individual whole‐brain resting‐state functional magnetic resonance imaging (MRI) scans in 39 AD patients (age 67 ± 8) and 43 healthy controls (age 69 ± 7). Between‐group differences were assessed by a permutation‐based method. Associations of EC with biomarkers for AD pathology in cerebrospinal fluid (CSF) and Mini Mental State Examination (MMSE) scores were assessed using Spearman correlation analysis. Decreased EC was found bilaterally in the occipital cortex in AD patients compared to controls. Regions of increased EC were identified in the anterior cingulate and paracingulate gyrus. Across groups, frontal and occipital EC changes were associated with pathological concentrations of CSF biomarkers and with cognition. In controls, decreased EC values in the occipital regions were related to lower MMSE scores. Our main finding is that ECM, a hypothesis‐free and computationally efficient analysis method of functional MRI (fMRI) data, identifies changes in brain network organization in AD patients that are related to cognition and underlying AD pathology. The relation between AD‐like EC changes and cognitive performance suggests that resting‐state fMRI measured EC is a potential marker of disease severity for AD. Hum Brain Mapp 35:2383–2393, 2014. © 2013 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Power, J. D., Barnes, K. A., Snyder, A. Z., Schlaggar, B. L., & Petersen, S. E. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.10.018 · Cited by 7,429 · cited 1×
“A student’s t-test was used to assess betweengroup differences in mean frame-wise displacement [Power et al., 2012] based on individual motion correction parameters.”
MethodSperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155 · cited 2×
“It is estimated that 20–40% of the healthy elderly population have amyloid plaque formation in the brain, possibly a sign of early stage AD [De Meyer et al., 2010; Mintun et al., 2006; Sperling et al., 2011].”
BackgroundNonparametric permutation tests for functional neuroimaging: A primer with examples
Nichols, T. E., & Holmes, A. P. (2002) · Human Brain Mapping · doi:10.1002/hbm.1058 · Cited by 6,256
SMITH, S., & NICHOLS, T. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2008.03.061 · Cited by 5,250
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806 · cited 1×
“It is assumed that amyloid accumulation starts years before clinical symptoms arise, and has already reached a plateau in an early stage of clinical AD [4,50].”
BackgroundWhat is cognitive reserve? Theory and research application of the reserve concept
STERN, Y. (2002) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617702813248 · Cited by 3,951
Greicius, M. D., Srivastava, G., Reiss, A. L., & Menon, V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308627101 · Cited by 3,684 · cited 4×
“These functional changes already occur in the early stages of AD [9,10], and consist of decreases as well as increases in local network connectivity [11-14].”
BackgroundMethodInfluentialExploring the brain network: A review on resting-state fMRI functional connectivity
van den Heuvel, M. P., & Hulshoff Pol, H. E. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.03.008 · Cited by 3,326
Toward discovery science of human brain function
Biswal, B. B., Mennes, M., Zuo, X.-N., Gohel, S., Kelly, C., Smith, S. M., Beckmann, C. F., Adelstein, J. S., Buckner, R. L., Colcombe, S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911855107 · Cited by 2,970
Buckner, R. L., Sepulcre, J., Talukdar, T., Krienen, F. M., Liu, H., Hedden, T., Andrews-Hanna, J. R., Sperling, R. A., & Johnson, K. A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5062-08.2009 · Cited by 2,862
The influence of head motion on intrinsic functional connectivity MRI
Van Dijk, K. R. A., Sabuncu, M. R., & Buckner, R. L. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.07.044 · Cited by 2,344
Buckner, R. L., Snyder, A. Z., Shannon, B. J., LaRossa, G., Sachs, R., Fotenos, A. F., Sheline, Y. I., Klunk, W. E., Mathis, C. A., Morris, J. C., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2177-05.2005 · Cited by 2,140 · cited 2×
“This region appears to be particularly vulnerable for AD pathology, as indicated by a convergence of amyloid deposition, hypometabolism, and atrophy in this region [Buckner et al., 2005, 2009; Drzezga et al., 2011; Minoshima et al., 1997; Mosconi et al., 2008; Scahill et al., 2002].”
BackgroundThe clinical use of structural MRI in Alzheimer disease
Frisoni, G. B., Fox, N. C., Jack, C. R., Scheltens, P., & Thompson, P. M. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.215 · Cited by 2,113
Self-citationMetabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease
Minoshima, S., Giordani, B., Berent, S., Frey, K. A., Foster, N. L., & Kuhl, D. E. (1997) · Annals of Neurology · doi:10.1002/ana.410420114 · Cited by 1,802 · cited 1×
“This region appears to be particularly vulnerable for AD pathology, as indicated by a convergence of amyloid deposition, hypometabolism, and atrophy in this region [Buckner et al., 2005, 2009; Drzezga et al., 2011; Minoshima et al., 1997; Mosconi et al., 2008; Scahill et al., 2002].”
BackgroundReduced resting-state brain activity in the “default network” in normal aging
Damoiseaux, J. S., Beckmann, C. F., Arigita, E. J. S., Barkhof, F., Scheltens, P., Stam, C. J., Smith, S. M., & Rombouts, S. A. R. B. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhm207 · Cited by 1,187 · cited 2×
“The data set was formed by combining two previously described restingstate fMRI data sets using the same scanning protocol [24,25].”
MethodSelf-citationComparing Brain Networks of Different Size and Connectivity Density Using Graph Theory
van Wijk, B. C. M., Stam, C. J., & Daffertshofer, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013701 · Cited by 1,161
Self-citation[ 11 C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease
Mintun, M. A., LaRossa, G. N., Sheline, Y. I., Dence, C. S., Lee, S. Y., Mach, R. H., Klunk, W. E., Mathis, C. A., DeKosky, S. T., & Morris, J. C. (2006) · Neurology · doi:10.1212/01.wnl.0000228230.26044.a4 · Cited by 1,036 · cited 1×
“It is estimated that 20–40% of the healthy elderly population have amyloid plaque formation in the brain, possibly a sign of early stage AD [De Meyer et al., 2010; Mintun et al., 2006; Sperling et al., 2011].”
BackgroundZhou, J., Greicius, M. D., Gennatas, E. D., Growdon, M. E., Jang, J. Y., Rabinovici, G. D., Kramer, J. H., Weiner, M., Miller, B. L., & Seeley, W. W. (2010) · Brain · doi:10.1093/brain/awq075 · Cited by 1,016
Neural basis of global resting-state fMRI activity
Schölvinck, M. L., Maier, A., Ye, F. Q., Duyn, J. H., & Leopold, D. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913110107 · Cited by 939 · cited 1×
“Resting-state functional MRI (fMRI) is used to study functional properties of the brain by detecting spontaneous neuronal activity as localized changes in the blood oxyhemoglobin/deoxyhemoglobin ratio [Scholvinck et al., 2010].”
MethodRombouts, S. A. R. B., Barkhof, F., Goekoop, R., Stam, C. J., & Scheltens, P. (2005) · Human Brain Mapping · doi:10.1002/hbm.20160 · Cited by 734 · cited 2×
“These functional changes already occur in the early stages of AD [9,10], and consist of decreases as well as increases in local network connectivity [11-14].”
BackgroundSelf-citationMosconi, L., Tsui, W. H., Herholz, K., Pupi, A., Drzezga, A., Lucignani, G., Reiman, E. M., Holthoff, V., Kalbe, E., Sorbi, S., et al. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.045385 · Cited by 726 · cited 1×
“This region appears to be particularly vulnerable for AD pathology, as indicated by a convergence of amyloid deposition, hypometabolism, and atrophy in this region [Buckner et al., 2005, 2009; Drzezga et al., 2011; Minoshima et al., 1997; Mosconi et al., 2008; Scahill et al., 2002].”
BackgroundSanz-Arigita, E. J., Schoonheim, M. M., Damoiseaux, J. S., Rombouts, S. A. R. B., Maris, E., Barkhof, F., Scheltens, P., & Stam, C. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013788 · Cited by 608
Self-citationDiagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People
De Meyer, G. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.179 · Cited by 462
Resting Brain Connectivity: Changes during the Progress of Alzheimer Disease
Zhang, H.-Y., Wang, S.-J., Liu, B., Ma, Z.-L., Yang, M., Zhang, Z.-J., & Teng, G.-J. (2010) · Radiology · doi:10.1148/radiol.10091701 · Cited by 320
Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia
Ossenkoppele, R., van der Flier, W. M., Zwan, M. D., Adriaanse, S. F., Boellaard, R., Windhorst, A. D., Barkhof, F., Lammertsma, A. A., Scheltens, P., & van Berckel, B. N. M. (2013) · Neurology · doi:10.1212/wnl.0b013e31827f0889 · Cited by 112 · cited 2×
“Furthermore, a recent positron emission tomography study that compared brain glucose metabolism in APOE e4-carriers and non-carriers, confirms that posterior brain function diminishing in AD is not limited to the precuneus but includes the occipital lobes as well [Ossenkoppele et al., 2013].”
BackgroundSelf-citation
Cited by
Modern network science of neurological disorders
Stam, C. J. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3801 · Cited by 1,307
Self-citationAmsterdam Dementia Cohort: Performing Research to Optimize Care
van der Flier, W. M., & Scheltens, P. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170850 · Cited by 390
Self-citationScheltens, P., Hallikainen, M., Grimmer, T., Duning, T., Gouw, A. A., Teunissen, C. E., Wink, A. M., Maruff, P., Harrison, J., van Baal, C. M., et al. (2018) · Alzheimer's Research & Therapy · doi:10.1186/s13195-018-0431-6 · Cited by 129
Self-citationKarim, H. T., Andreescu, C., Tudorascu, D., Smagula, S. F., Butters, M. A., Karp, J. F., Reynolds, C., & Aizenstein, H. J. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.55 · Cited by 95
Latif-Hernandez, A., Shah, D., Craessaerts, K., Saido, T., Saito, T., De Strooper, B., Van der Linden, A., & D’Hooge, R. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.11.017 · Cited by 92
Metadata
- Authors
- Binnewijzend, M. A. A., Adriaanse, S. M., Van der Flier, W. M., Teunissen, C. E., de Munck, J. C., Stam, C. J., Scheltens, P., van Berckel, B. N. M., Barkhof, F., & Wink, A. M.
- Venue
- Human Brain Mapping
- Publisher
- Wiley
- Published
- 2013-09-03
- Volume
- 35
- Issue
- 5
- Pages
- 2383-2393
- ISSN
- 1065-9471 (ISSN-L)
- 1097-0193
- OpenAlex
- W1497201830
- Cited by
- 127
- References
- 25
- FWCI
- 5.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.